Spirocyclic Scaffolds in Medicinal Chemistry

被引:356
|
作者
Hiesinger, Kerstin [1 ]
Dar'in, Dmitry [2 ]
Proschak, Ewgenij [1 ]
Krasavin, Mikhail [2 ]
机构
[1] Goethe Univ, Inst Pharmaceut Chem, D-60348 Frankfurt, Germany
[2] St Petersburg State Univ, Inst Chem, St Petersburg 199034, Russia
基金
俄罗斯科学基金会;
关键词
SMALL-MOLECULE INHIBITORS; RECEPTOR ANTAGONISTS; GPR40; AGONISTS; HIGH-AFFINITY; DISCOVERY; POTENT; FENSPIRIDE; OPTIMIZATION; PROLINE; DESIGN;
D O I
10.1021/acs.jmedchem.0c01473
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Spirocyclic scaffolds are incorporated in various approved drugs and drug candidates. The increasing interest in less planar bioactive compounds has given rise to the development of synthetic methodologies for the preparation of spirocyclic scaffolds. In this Perspective, we summarize the diverse synthetic routes to obtain spirocyclic systems. The impact of spirocycles on potency and selectivity, including the aspect of stereochemistry, is discussed. Furthermore, we examine the changes in physicochemical properties as well as in in vitro and in vivo ADME using selected studies that compare spirocyclic compounds to their nonspirocyclic counterparts. In conclusion, the value of spirocyclic scaffolds in medicinal chemistry is discussed.
引用
收藏
页码:150 / 183
页数:34
相关论文
共 50 条
  • [21] The utilization of spirocyclic scaffolds in novel drug discovery
    Zheng, Ya-Jun
    Tice, Colin M.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 831 - 834
  • [22] Fragment-to-Lead Medicinal Chemistry Publications in 2021
    Walsh, Louise
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Woodhead, Andrew
    Wren, Ella
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (02) : 1137 - 1156
  • [23] Fragment-to-Lead Medicinal Chemistry Publications in 2016
    Johnson, Christopher N.
    Erlanson, Daniel A.
    Jahnke, Wolfgang
    Mortenson, Paul N.
    Rees, David C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 1774 - 1784
  • [24] Fragment-to-Lead Medicinal Chemistry Publications in 2015
    Johnson, Christopher N.
    Erlanson, Daniel A.
    Murray, Christopher W.
    Rees, David C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (01) : 89 - 99
  • [25] Fragment-to-Lead Medicinal Chemistry Publications in 2019
    Jahnke, Wolfgang
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Johnson, Christopher N.
    Mortenson, Paul N.
    Ochi, Yuji
    Urushima, Tatsuya
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15494 - 15507
  • [26] Fragment-to-Lead Medicinal Chemistry Publications in 2018
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    Mortenson, Paul N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4430 - 4444
  • [27] Celebrating the Medicinal Chemistry of Gunda Georg and Shaomeng Wang
    Bolognesi, Maria Laura
    Conway, Stuart J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17541 - 17544
  • [28] Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry
    Jones, Lyn H.
    Summerhill, Nicholas W.
    Swain, Nigel A.
    Mills, James E.
    MEDCHEMCOMM, 2010, 1 (05) : 309 - 318
  • [29] Medicinal chemistry matters - a call for discipline in our discipline
    Johnstone, Craig
    DRUG DISCOVERY TODAY, 2012, 17 (11-12) : 538 - 543
  • [30] Innovative medicinal chemistry strategies for enhancing drug solubility
    He, Zhangxu
    Yang, Weiguang
    Yang, Feifei
    Zhang, Jingyu
    Ma, Liying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 279